Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) EPS (Basic) (2021 - 2025)

Biote has reported EPS (Basic) over the past 5 years, most recently at $0.08 for Q4 2025.

  • Quarterly results put EPS (Basic) at $0.08 for Q4 2025, down 23.98% from a year ago — trailing twelve months through Dec 2025 was $0.88 (up 636.35% YoY), and the annual figure for FY2025 was $1.01, up 1022.25%.
  • EPS (Basic) for Q4 2025 was $0.08 at Biote, down from $0.26 in the prior quarter.
  • Over the last five years, EPS (Basic) for BTMD hit a ceiling of $1.22 in Q2 2021 and a floor of -$0.39 in Q1 2023.
  • Median EPS (Basic) over the past 5 years was $0.08 (2021), compared with a mean of $0.09.
  • Peak annual rise in EPS (Basic) hit 12575.05% in 2023, while the deepest fall reached 1400.0% in 2023.
  • Biote's EPS (Basic) stood at -$0.05 in 2021, then skyrocketed by 540.0% to $0.22 in 2022, then soared by 45.45% to $0.32 in 2023, then plummeted by 65.62% to $0.11 in 2024, then decreased by 23.98% to $0.08 in 2025.
  • The last three reported values for EPS (Basic) were $0.08 (Q4 2025), $0.26 (Q3 2025), and $0.1 (Q2 2025) per Business Quant data.